The Latest in Pharmacy

Gene therapy granted orphan designation for hemophilia A

March 4, 2016

EC approves drug for iron-deficiency anemia in IBD

March 2, 2016

Drug granted orphan designation for hemolytic anemia

March 1, 2016

CHMP recommends fusion protein for hemophilia B

March 1, 2016

EC grants venetoclax orphan designation for AML

March 1, 2016

FDA approves obinutuzumab for FL

February 27, 2016

Orphan designation recommended for BTK inhibitor

February 26, 2016

FDA investigates issues with rivaroxaban trial

February 25, 2016

Adjunct T-cell therapy granted orphan designation

February 24, 2016

Product approved to treat hemophilia A in EU

February 23, 2016

Antiplatelet agent approved for long-term use

February 23, 2016

Drug granted breakthrough designation for AML

February 20, 2016

Health Canada approves ruxolitinib for PV

February 19, 2016

Development of myelofibrosis drug on hold

February 11, 2016

MF drug trials placed on partial clinical hold

February 9, 2016